X0306 4 2017-06-13 false 0001557883 Dermira, Inc. DERM 0001014095 CRAVES FRED B C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025 true false true false Common Stock 3441075.00 I See footnote Common Stock 65572.00 I See footnote Director Stock Option (right to buy) 28.01 2017-06-13 4 A false 6000.00 0.00 A 2027-06-12 Common Stock 6000.00 6000.00 D Restricted Stock Unit 2017-06-13 4 A false 3000.00 0.00 A Common Stock 3000.00 3000.00 D The securities are held directly by Bay City Capital Fund V, L.P. ("Fund V"). Dr. Craves disclaims beneficial ownership over the securities owned by Fund V, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Fund V's general partner, Bay City Capital Management V LLC. The securities are held directly by Bay City Capital Fund V Co-Investment Fund, L.P. ("Co-Investment V"). Dr. Craves disclaims beneficial ownership over the securities owned by Co-Investment V, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in Bay City Capital LLC, which is the manager of Co-Investment V's general partner, Bay City Capital Management V LLC. The stock option will vest and become exercisable as to 100% of the shares on June 13, 2018, subject to the continuing service of the Reporting Person on such vesting date. Each RSU represents a contingent right to receive one share of DERM common stock. The RSU will vest 100% of the shares on June 13, 2018, subject to the continuing service of the Reporting Person on such vesting date. /s/ Fred B. Craves 2017-06-15